Home  - Health_Conditions - Myelodysplastic Syndromes

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

81-86 of 86    Back | 1  | 2  | 3  | 4  | 5

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Myelodysplastic Syndromes:     more books (49)

100 Questions & Answers About Myelodysplastic Syndromes by Jason Gotlib, 2007-12-28 21st Century Ultimate Medical Guide to Myelodysplastic Syndromes (Preleukemia, Smoldering Leukemia) - Clinical Information for Physicians and Patients, Treatment Options (Two CD-ROM Set) by PM Medical Health News, 2009-01-28 Medifocus Guidebook on: Myelodysplastic Syndromes by Inc. Medifocus.com, 2010-03-25 Myelodysplastic Syndrome - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications, 2004-04-26 Myelodysplastic Syndromes: Clinical and Biological Advances Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition (Basic and Clinical Oncology) Myelodysplastic Syndromes & Secondary Acute Myelogenus Leukemia: Directions for the New Millennium (Cancer Treatment and Research) The Official Patient's Sourcebook on Myelodysplastic Syndromes: A Revised and Updated Directory for the Internet Age by Icon Health Publications, 2002-11 The Myelodysplastic Syndromes: Pathobiology and Clinical Management (Basic & Clinical Oncology, 27) The Myelodysplastic Syndromes by G. J. Mufti, 1992-08 MyelodysplasticSyndromes (Hematologic Malignancies) by H. J. Deeg, D.T. Bowen, et all 2005-12-05 Myelodysplastic Syndromes: Pathophysiology and Treatment : Proceedings of the Kyoto Symposium on Myelodysplastic Syndromes, Pathophysiology and Treatment, ... August 1987 (International Congress Series) by Kyoto Symposium on Myelodysplastic Syndromes: Pathophysiology and Treatment (1987), Haruto Uchino, et all 1987-12 The Myelodysplastic Syndromes Myelodysplastic Syndromes. Advances in Research and Treatment by Tokyo, Japan) International Symposium on Myelodysplastic Syndromes (1994 : National Cancer Center, 1995-09-01

lists with details

81. Information About EORTC Protocols
    remission induction chemotherapy followed by an autologous or allogeneic bone marrowtransplantation for bad prognosis myelodysplastic syndromes (MDS) and  
    http://www.eortc.be/protoc/listprot.asp?kind=sites&site=18

82. Myelodysplastic Syndromes
    myelodysplastic syndromes. Back to previous level Anemia, Refractory1 more specific term/s, 0 more link/s Search PUBMED for Anemia  
    http://www.ohsu.edu/cliniweb/C15/C15.378.190.625.html

83. BACKGROUND OF THE DISEASE CALLED MYELODYSPLASTIC SYNDROMES OR MDS
    BACKGROUND OF THE DISEASE CALLED myelodysplastic syndromes OR MDSMyelodysplasticsyndromes is not a single disease, but a group of disorders primarily  
    http://www.myelodysplasticsyndrome.com/Clinical_Presentation.html
    
    Extractions: BACKGROUND OF THE DISEASE CALLED MYELODYSPLASTIC SYNDROMES OR MDS: Myelodysplastic syndromes is not a single disease, but a group of disorders primarily affecting the bone marrow, with the abnormality most prominently reflected in a lowering of blood counts. There are two main forms of blood cells; lymphoid and myeloid. MDS, as the name implies, is a disease of the myeloid cells. The term simply means that the myeloid blood cells in the blood (as opposed to lymphoid), and their precursors in the bone marrow, look abnormal (dysplastic). The disease usually strikes older individuals, about half the patients being more than 65 years of age. There are two types of MDS, one for which no cause is known called primary MDS, and the other which follows known and documented exposure to toxic/chemical agents such as chemotherapy or radiation, called secondary MDS. The vast majority of patients constituting approximately 90% in all, belong to the primary MDS category, while in 10% cases, the disease is a result of damage to the marrow produced by chemicals such as chemotherapy for a prior malignancy or exposure to radiation. Patients invariably present with low blood counts.

84. DIAGNOSIS - MYELODYSPLASTIC SYNDROMES
    myelodysplastic syndromes The myelodysplastic syndromes are a group of marrow diseasescharacterized by progressive decline in the blood counts and potential  
    http://www.hackensackstemcell.com/adult-diagnosis/myelody.html
    
    Extractions: Most patients first discover their disease when they have recurrent infections, bleeding or extreme fatigue. As the bone marrow fills up with abnormal cancer cells (known as blasts) or the bone marrow becomes more abnormal (dysplastic), the normal bone marrow cells decrease in number. Thus patients may have low numbers of red blood cells (the cells that carry oxygen and nutrients), low numbers of platelets (the cells that help with clotting), and low numbers of normal white blood cells (the cells that fight infections). The prognosis of these diseases is quite variable. Refractory anemia (with or without ringed sideroblasts) is a slowly progressive disease with survivals often in the range of 7-10 years. Refractory anemia with blasts (excess or blasts in transition) are much more aggressive diseases in which patients are at risk of immediate infection and bleeding complications and diseases which may progress to leukemia in under 2 years. Treatment of the myelodysplastic diseases has been quite difficult. Many patients are too old to withstand aggressive therapy such as chemotherapy. Transfusions of blood and antibiotic treatments are common. In younger patients, combination chemotherapy (which medications such as topotecan and cytarabine) may result in temporary remissions.

85. SOTS Myelodysplastic Syndrome Conference Oct. 30 - 31, 2000
    and agents Immunosuppressive therapy shows promise in MDS based on similarity toaplastic anemia and other bone marrow failure syndromes - Studies of growth  
    http://www.webtie.org/sots/Meetings/Leukemia/10-30-2000/Default.htm

86. Second International Congress Myeloproliferative Diseases And Myelodysplastic Sy
    Second International Congress Myeloproliferative Diseases And MyelodysplasticSyndromes First Announcement Call for Abstracts. Hilton  
    http://www.imedex.com/announcements/silver03.htm
    
    Extractions: Fax: +1 (212) 315 1374 Conference Support Sponsorship opportunities are available to companies interested in supporting this conference. For details, please contact Piper Gray at at +1 (770) 751 7332 or send e-mail to sponsor@imedex.com Chairmen Conference Location Conference Support ... Home Conference Organizer

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

81-86 of 86    Back | 1  | 2  | 3  | 4  | 5